Collaborations & Business Partnerships

Collaborations & Business Partnerships

The Vifor Pharma Group has a rich history of business partnerships with both local and leading multi-national companies across the world. Our partnership business model enables us to reach patients in key pharmerging markets where there is a high, unmet medical need.

Key Pharmerging Markets

We invest our resources where they will have the greatest positive impact on patients. Our first step is to work with our partners to develop a deep understanding of the critical success factors and relevant stakeholders in each of these markets so that we make the right decisions and investments.

Importantly, we remain loyal to our business partners and committed to the long term while remaining agile and ready to capitalize on new market opportunities.

Current priorities include optimising the market expansion of Ferinject®, successfully launching Veltassa® and ensuring launch readiness for Vifor Pharma Group’s evolving cardio-renal pipeline. Renown companies we cooperate with across the globe include: 

  • 4Life Pharma
  • Abdi İbrahim 
  • Abiogen Pharma  
  • Aspen Pharmacare 
  • Astellas Pharma  
  • Barsian Darou 
  • ChemoCentryx 
  • CTS Chemical Industries 
  • Daiichi Sankyo 
  • Diethelm Keller Group 
  • Dr. Reddy’s  Emcure Pharmaceuticals 
  • Fresenius Kabi 
  • Fresenius Medical Care 
  • Genesis Pharma 
  • Grünenthal 
  • Helsinn Healthcare 
  • Hikma Pharmaceutical
  • Imporfar Industria Farmaceutica del Caribe (INFACA) 
  • JW Pharmaceutical 
  • Kissei Pharmaceutical 
  • Laboratorios LETI 
  • Lek Pharmaceuticals 
  • Luitpold Pharmaceuticals 
  • Lupin  
  • Merck 
  • Nichi-Iko Pharmaceutical 
  • OBS Pakistan 
  • OPKO Health 
  • Pfizer 
  • Pharmalog  
  • Quimica Suiza 
  • Roche 
  • Sandoz 
  • Sandi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) 
  • Takeda 
  • Teva Pharmaceutical Industries 
  • UCB Pharma  
  • Zeria Pharmaceutical 
  • Zuoz Pharma